📰 Jack Anders News
Jack Anders News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Anders. Real-time updates on events, politics, business and more.
June 10, 2024
Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]
June 7, 2024
Bain Capital Life Sciences Investors LLC bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines comprises 3.1% of Bain Capital Life […]
June 7, 2024
Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […]
June 1, 2024
The Greenville County Coroner's Office identified a paraglider that crashed in Greenville County.
May 25, 2024
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $40.63 and last traded at $40.05, with a volume of 295845 shares trading hands. The stock had previously closed at $39.66. Analyst Upgrades and Downgrades Several research analysts have issued reports […]
May 6, 2024
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $40.03, for a total value of $400,300.00. Following the completion of the transaction, the chief financial officer now directly […]
May 6, 2024
Revolution Medicines (NASDAQ:RVMD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Revolution […]
April 12, 2024
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price upped by Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 20.29% from the company’s current […]
April 10, 2024
Revolution Medicines (NASDAQ:RVMD – Get Free Report) was upgraded by equities research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Wednesday, MarketBeat reports. The brokerage presently has a $48.00 target price on the stock, up from their prior target price of $36.00. Raymond James’ […]
April 9, 2024
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are covering the company, Marketbeat reports. Ten analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have issued a report on the stock in the last […]